Small volume Parenterals
|
Opthalmic range
Sr. No. |
Brand Name |
Product Name |
Volume |
Container |
1 |
Nircip |
Ciprofloxacin Eye/ Ear drops |
5, 10 ml |
Plastic ampoule |
2 |
Nircip- D |
Ciprofloxacin + Dexamethazone eye/ ear drops |
5, 10 ml |
Plastic ampoule |
3 |
Nirnorf |
Norfloxacin Eye/ Ear drops |
5, 10 ml |
Plastic ampoule |
4 |
Nirflox |
Oflloxacin Eye/ Ear drops |
5, 10 ml |
Plastic ampoule |
5 |
Nirflox D |
Ofloxacin + Dexamethazone eye/ ear drops |
5, 10 ml |
Plastic ampoule |
6 |
Nirmycin-D |
Neomycine sulphate + Dexamethazone eye drops |
5, 10 ml |
Plastic ampoule |
7 |
Nirchlor- D |
Chloramphenicol + Dexamethazone eye drops |
5, 10 ml |
Plastic ampoule |
8 |
Tobranir |
Tobramycin eye/ ear drops |
5, 10 ml |
Plastic ampoule |
9 |
Tobranir-D |
Tobramycine + Dexamethazone eye/ ear drops |
5, 10 ml |
Plastic ampoule |
10 |
Nirgent |
Gentamycine Eye/ ear drops |
5, 10 ml |
Plastic ampoule |
11 |
Nirgent- D |
Gentamycine + Dexamethazone Eye/ ear drops |
5, 10 ml |
Plastic ampoule |
12 |
Dexamethazone |
Dexamethazone sodium |
1 ml |
Glass ampoule |
|
USP – United States Pharmacopoeia, BP – British Pharmacopoeia, CP – Chinese Pharmacopoeia,
EP – European Pharmacopoeia, JP – Japanese Pharmacopoeia, ***
Product exploitation, including development, sales and offer for sale are performed where permissible by patent law. This presentation is not and should not constitute as an offer for sale in territories where it is not permitted by law.